Butterfly Network (BFLY) Net Cash Flow Growth (1y) (2021 - 2026)
Butterfly Network (BFLY) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 76.43% |
| 10 | Butterfly Network | 1.76 Bn | 1.62 Bn | 18.29 Mn | -118.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.87% |
| Dec 31, 2025 | 224.55% |
| Sep 30, 2025 | 53.16% |
| Jun 30, 2025 | 33.86% |
| Mar 31, 2025 | 404.69% |
| Dec 31, 2024 | 67.83% |
| Sep 30, 2024 | 50.80% |
| Jun 30, 2024 | 60.71% |
| Mar 31, 2024 | -169.00% |
| Dec 31, 2023 | 49.96% |
| Sep 30, 2023 | 85.85% |
| Jun 30, 2023 | 46.51% |
| Mar 31, 2023 | 154.31% |
| Dec 31, 2022 | -111.58% |
| Sep 30, 2022 | -189.52% |
| Jun 30, 2022 | -1,170.62% |
| Mar 31, 2022 | -40.71% |
| Dec 31, 2021 | 3,063.32% |
| Sep 30, 2021 | 715.04% |
| Jun 30, 2021 | 38.95% |